Individualized treatment with infliximab therapy in children with Crohn’s disease support shorter time intervals between infusions

OBJECTIVES: To study the effect of an individualized treatment approach with regard to dosage intervals between infliximab infusions on the clinical outcome of pediatric Crohn’s disease (CD). PATIENTS AND METHODS: A retrospective analysis of medical records of all pediatric patients with CD who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommar, M., Eksborg, S., Hildebrand, H., Grahnquist, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980724/
https://www.ncbi.nlm.nih.gov/pubmed/27536423
http://dx.doi.org/10.3109/21556660.2012.655815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980724/
https://www.ncbi.nlm.nih.gov/pubmed/27536423
http://dx.doi.org/10.3109/21556660.2012.655815

Ejemplares similares